p53-Degradation by HPV-16 E6 preferentially affects the removal of cyclobutane pyrimidine dimers from non-transcribed strand and sensitizes mammary epithelial cells to UV-irradiation

Mutation Research - DNA Repair

Volumn 459, Issue 2, 2000, Pages 135-145

  El Mahdy, Mohammed A ^a,b   Hamada, Farid M ^b   Wani, Manzoor A ^a   Zhu, Qianzheng ^a   Wani, Altaf A ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b Al Azhar University   (Egypt)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Cyclobutane pyrimidine dimers; DNA repair; Human mammary epithelial cells; p53

Indexed keywords

CYCLOBUTANE; PYRIMIDINE DIMER;

APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; EXCISION REPAIR; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; ULTRAVIOLET RADIATION; WART VIRUS; WESTERN BLOTTING;

APOPTOSIS; BREAST; CELLS, CULTURED; DNA REPAIR; EPITHELIAL CELLS; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PYRIMIDINE DIMERS; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 0034689558     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(99)00066-X     Document Type: Article

References (50)

1. Ford J.M., Hanawalt P.C. Role of DNA excision repair gene defects in the etiology of cancer. Curr. Top. Microbiol. Immunol. 221:1997;47-70.
2. Dumaz N., Drougard C., Sarasin A., Daya-Grosjean L. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc. Natl. Acad. Sci. U. S. A. 90:1993;10529-10533.
3. S.M. D'Ambrosio, A.A. Wani, Repair of O-alkylation damage in human cells, in: G.E. Milo, B. Casto (Eds.), Transformation of Human Diploid Fibroblasts: Molecular and Genetic Mechanisms, CRC Press, Baco Raton, 1989, pp. 79-97.
4. Sancar A. DNA excision repair. Annu. Rev. Biochem. 65:1996;43-81.
5. Ford J.M., Hanawalt P.C. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J. Biol. Chem. 272:1997;28073-28080.
6. Kovacs E., Almendral A. Reduced DNA repair synthesis in healthy women having first degree relatives with breast cancer. Eur. J. Cancer Clin. Oncol. 23:1987;1051-1057.
7. Weinberg R.A. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res. 49:1989;3713-3721.
8. Ames B.N., Shigenaga M.K., Gold L.S. DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis. Environ. Health Perspect. 101:1993;35-44. Suppl. 5.
9. Holmquist G.P., Gao S.W. Somatic mutation theory, DNA repair rates, and the molecular epidemiology of p53 mutations. Mutat. Res. Rev. Mutat. Res. 386:1997;69-101.
10. Smith M.L., Chen I.T., Zhan Q., Bae I., Chen C.-Y., Gilmer T.M., Kastan M.B., O'Connor P.M., Fornace A.J. Jr. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science. 266:1994;1376-1380.
11. Wang X.W., Forrester K., Yeh H., Feitelson M.A., Gu J.-R., Harris C.C. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl. Acad. Sci. U. S. A. 91:1994;2230-2234.
12. Wang X.W., Yeh H., Schaeffer L., Roy R., Moncollin V., Egly J.-M., Wang Z., Friedberg E.C., Evans M.K., Taffe B.G., Bohr V.A., Weeda G., Hoeijmakers J.H.J., Forrester K., Harris C.C. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet. 10:1995;188-195.
13. 1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
14. Lowe S.W., Ruley H.E., Jacks T., Housman D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967.
15. Wani M.A., Zhu Q.Z., El-mahdy M., Wani A.A. Influence of p53 tumor suppressor protein on bias of DNA repair and apoptotic response in human cells. Carcinogenesis. 20:1999;765-772.
16. Smith M.L., Chen I.-T., Zhan Q., O'Connor P.M., Fornace A.J. Jr. Involvement of the p53 tumor suppressor in repair of u.v.- type DNA damage. Oncogene. 10:1995;1053-1059.
17. Ford J.M., Hanawalt P.C. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl. Acad. Sci. U. S. A. 92:1995;8876-8880.
18. McKay B.C., Francis M.A., Rainbow A.J. Wildtype p53 is required for heat shock and ultraviolet light enhanced repair of a UV-damaged reporter gene. Carcinogenesis. 18:1997;245-249.
19. Ford J.M., Baron E.L., Hanawalt P.C. Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation. Cancer Res. 58:1998;599-603.
20. Katherine K.S., Floyd M.P., Johng S.R., Martha R.S., Ram P. Role of DNA repair in malignant neoplastic transformation of human mammary epithelial cells in culture. Carcinogenesis. 13:1992;1137-1141.
21. Stampfer M.R. Isolation and growth of human mammary epithelial cells. J. Tissue Cult. Methods. 9:1985;107-115.
22. Band V., Sager R. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc. Natl. Acad. Sci. U. S. A. 86:1989;1249-1253.
23. Venkatachalam S., Denissenko M., Wani A.A. Modulation of (±)-anti-BPDE mediated p53 accumulation by inhibitors of protein kinase C and poly(ADP-ribose) polymerase. Oncogene. 14:1997;801-809.
24. Scudiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S., Nofzinger T.H., Currens M.J., Seniff, Boyd M.R. Evaluation of soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:1988;4827-4833.
25. Venkatachalam S., Denissenko M.F., Alvi N., Wani A.A. Rapid activation of apoptosis in human promyelocytic leukemia cells by (±)-anti-benzo[a]pyrene-diol epoxide induced DNA damage. Biochem. Biophys. Res. Commun. 197:1993;722-729.
26. Venkatachalam S., Denissenko M.F., Wani A.A. DNA repair in human cells: quantitative assessment of bulky anti-BPDE DNA adducts by non-competitive immunoassays. Carcinogenesis. 16:1995;2029-2036.
27. Wani A.A., D'Ambrosio S.M., Alvi N.K. Quantitation of pyrimidine dimers by immunoslot blot following sublethal UV-irradiation of human cells. Photochem. Photobiol. 46:1987;477-482.
28. Wani A.A., Gibson-D'Ambrosio R.E., D'Ambrosio S.M. Antibodies to UV irradiated DNA: the monitoring of DNA damage by ELISA and indirect immunofluorescence. Photochem. Photobiol. 40:1984;465-471.
29. Chen J.X., Kisleyou A.S., Harvey R.G., Slaga T.J., Morris R.J., Tang M.S. Using UvrABC nuclease to detect 7,12-dimethylbenz[a]anthracene anti-diol epoxide DNA binding specificity in the mouse H-ras gene. Chem. Res. Toxicol. 9:1996;1350-1354.
30. Chen R.H., Maher V.M., Brouwer J., Putte P.V.D., McCormick J.J. Preferential repair and strand-specific repair of benzo[a]pyrene diol epoxide adducts in the HPRT gene of diploid human fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 89:1992;5413-5417.
31. 32P -labeled single-stranded DNA probes using linear PCR; application of the method for analysis of strand-specific DNA repair Mutat. Res. DNA Repair. 315:1994;189-195.
32. Denissenko M.F., Venkatachalam S., Yamasaki E.F., Wani A.A. Assessment of DNA damage and repair in specific genomic regions by quantitative immuno-coupled PCR. Nucleic Acids Res. 22:1994;2351-2359.
33. Wazer D.E., Liu X.-L., Chu Q., Gao Q., Band V. Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc. Natl. Acad. Sci. U. S. A. 92:1995;3687-3691.
34. Hawkins D.S., Demers G.W., Galloway A. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res. 56:1996;892-898.
35. Fan S., El-Deiry W.S., Bae I., Freeman J., Jondle D., Bhatia K., Fornace A.J. Jr., Magrath I., Kohn K.W., O'Connor P.M. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res. 54:1994;5824-5830.
36. O'Connor P.M., Jackman J., Jondle D., Bhatia K., Magrath I., Kohn K.W. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res. 53:1993;4780.
37. Lowe S.W., Bodis S., McClatchey A., Remington L., Ruley H.E., Fisher D.E., Housman D.E., Jacks T. p53 status and the efficacy of cancer therapy in vivo. Science. 266:1994;807-810.
38. Brachman D.G., Beckett M., Graves D., Haraf D., Vokes E., Weichselbaum R.R. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell line. Cancer Res. 53:1993;3667-3669.
39. Fan S., Smith M.L., Rivet D.J. II, Duba D., Zhan Q., Kohn K.W., Fornace A.J. Jr., O'Connor P.M. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res. 55:1995;1649-1654.
40. Livingstone L.R., White A., Sprouse J., Livanos E., Jacks T., Tlsty T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell. 70:1992;923-935.
41. Yin Y., Tainsky M.A., Bischoff F.Z., Strong L.C., Wahl G.M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell. 70:1992;937-948.
42. Cross S.M., Sanchez C.A., Morgan C.A., Schimke M.K., Ramel S., Idzerda R.L., Raskind W.H., Reid B.J. A p53-dependent mouse spindle checkpoint. Science. 267:1995;1353-1356.
43. Michieli P., Chedi M., Lin D., Pierce J.H., Mercer W.E., Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54:1994;3391-3395.
44. Johnson M., Dimitrov D., Vojta P.J., Barret C., Noda A., Pereira-Smith O.M., Smith J.R. Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol. Carcinog. 11:1994;59-64.
45. Jiang H., Lin J., Su Z., Collart F.R., Huberman E., Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene. 9:1994;3397-3406.
46. McKay B.C., Ljungman M., Rainbow A.J. Potential roles for p53 in nucleotide excision repair. Carcinogenesis. 20:1999;1389-1396.
47. WAF1-dependent growth arrest as the possible mechanism of abnormal resistance to ultraviolet light cytotoxicity in Li-Fraumeni syndrome fibroblast strains heterozygous for TP53 mutations. Oncogene. 17:1998;533-543.
48. Xu C., Meikrantz W., Schlegel R., Sager R. The human papilloma virus 16E6 gene sensitizes human mammary epithelial cells to apoptosis induced by DNA damage. Proc. Natl. Acad. Sci. U. S. A. 92:1995;7829-7833.
49. McKay B.C., Ljungman M., Rainbow A.J. Persistent DNA damage induced by ultraviolet light inhibits p21waf1 and bax expression: implications for DNA repair, UV sensitivity and the induction of apoptosis. Oncogene. 17:1998;545-555.
50. Cip/Waf1 cyclin-kinase inhibitor in ap53-independent manner. Exp. Cell Res. 248:1999;272-279.